Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1997-03-13
2000-06-27
Housel, James C.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 934, 424 9348, 4242411, A01N 6300, A61K 39108
Patent
active
060804009
ABSTRACT:
The present invention includes methods for generating neutralizing antitoxin directed against verotoxins. In preferred embodiments, the antitoxin directed against these toxins is produced in avian species using soluble recombinant verotoxin proteins. This antitoxin is designed so as to be administrable in therapeutic amounts and may be in any form (i.e., as a solid or in aqueous solution). These antitoxins are useful in the treatment of humans and other animals intoxicated with at least one bacterial toxin, as well as for preventive treatment, and diagnostic assays to detect the presence of toxin in a sample.
REFERENCES:
patent: 5532142 (1996-07-01), Johnston et al.
DWK Acheson et al. Comparison of Shoga-like toxin I B-subunit expression and localization in E. coli and V. cholerae by using trc or iron-regulated promoter systems. Infect. Immun. 61: 1098-11104, 1993.
DWK Acheson et al. Expression and purification of Shiga-like toxin II B subunits. Infect. Immun. 63: 301-308, 1995.
K. Ramotar et al. Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron. Biochem. J. 272: 805-811, 1990.
TM Zollman et al. Purification of recombinant Shiga-like toxin type I A1 fragment from E. coli. Protein Expression and Purification 5: 291-295, 1994.
SB Calderwood et al. A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit. Infect. Immun. 58: 2977-2982, 1990.
I Muhldorfer et al. Regulation of the Shiga-like toxin II operon in E. coli. Infect. Immun. 64: 495-502, 1996.
F. Gunzer et al. J. Clin. Microbiol. 31: 2604-2610, 1993.
R. Mierendorf et al. inNovations 1(1): 1-3, 1994.
MP Jackson et al. FEMS microbiol. Lett. 44: 109-114, 1987.
LP Perera et al. Infect. Immun. 59: 829-835, 1991.
Byrne Lisa Marie
Williams James A.
Devi S.
Housel James C.
Ophidian Pharmaceuticals Inc.
LandOfFree
Compositions for the prevention and treatment of verotoxin-induc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the prevention and treatment of verotoxin-induc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the prevention and treatment of verotoxin-induc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1781956